Why Lung Cancer Diagnosis in Women Deserves A Closer Study

Most people still picture lung cancer as a disease of older men with decades of smoking behind them. That picture is out of date.

Lung cancer is the deadliest cancer for American women. The American Cancer Society estimates about 61,950 women will die of lung cancer in 2026, and it is the leading cause of cancer death in New York.

When symptoms in a woman who doesn’t fit the old profile are explained away instead of investigated, the delay can be the difference between a tumor that could be removed and one that has already spread.

If that happened to you or someone in your family, here is what to understand about why it happens, and when it crosses the line into a lung cancer malpractice claim.

The Numbers Have Shifted Toward Younger Women

For most of the last century, men were diagnosed with lung cancer far more often than women. Among younger adults, that pattern has reversed. According to the American Cancer Society, lung cancer incidence in women under 65 surpassed the rate in men for the first time in 2021.

That is part of a broader shift in which cancer rates in women under 50 now run 82% higher than in men of the same age.

Researchers have not settled on a single explanation. Smoking trends, radon and other environmental exposures, and the biology of tumors that develop in women are all being studied.

What matters for patients right now is simpler: a younger woman with lingering respiratory symptoms is not the low-risk lung cancer patient that many doctors were trained to assume.

Lung Cancer in Women Who Never Smoked

A woman does not have to smoke to get lung cancer. In a CDC analysis of more than 129,000 patients across seven states, 12.5% of people diagnosed with lung cancer had never smoked. The share was higher in women than in men at every age (15.7% versus 9.6%). Among women ages 20 to 49, it reached 27.7%, meaning more than one in four younger women with lung cancer had never smoked.

These cancers are often biologically different from smoking-related tumors. Most are adenocarcinomas, the lung cancer subtype seen more often in women, in younger patients, and in people who never smoked.

They are more likely to carry targetable mutations such as EGFR, which is why biomarker testing matters so much once a diagnosis is made. Researchers are also studying whether hormones play a role, though that work is not settled.

The diagnostic problem is predictable. When a patient tells her doctor she has never smoked, lung cancer tends to slide down the list of possibilities. Each alternative explanation can seem reasonable in isolation:

• A persistent cough becomes bronchitis, asthma, or reflux.

• Chest pain becomes a pulled muscle or anxiety.

• Fatigue becomes stress or anemia.

The danger comes when those explanations are never tested against the obvious next step. If symptoms persist and no one orders a chest X-ray or CT scan, the cancer keeps growing.

Our page on lung cancer signs and symptoms lists the warning signs that should prompt a closer look.

The Screening Gap

Lung cancer screening with a yearly low-dose CT scan is one of the best tools for catching the disease early. Under the federal guidelines New York follows, screening is recommended for adults 50 to 80 with at least a 20 pack-year smoking history who still smoke or quit within the past 15 years. Our page on lung cancer screening protocols explains those criteria in more detail.

A 45-year-old woman who never smoked does not qualify, no matter how long she has been coughing. Radon in her home, a mother who died of lung cancer, or years of workplace exposure don’t change that.

The groups driving the rise in young-onset and never-smoker lung cancer are largely outside the screening program entirely.

Even eligible New Yorkers are mostly going unscreened. The state reports that about 648,000 residents meet the criteria, yet only about 1 in 5 had a screening scan in the past year.

Screening and diagnosis are two different things. Screening is for people with no symptoms. A woman who walks into an exam room with a cough that won’t quit, unexplained weight loss, or blood in her phlegm is not a screening candidate. She is a patient with symptoms who needs a diagnostic workup. Whether she “qualifies for screening” has nothing to do with whether her doctor should order imaging.

What to Do If You Suspect a Delayed Diagnosis

Start by requesting your complete medical records: every visit where you reported symptoms, every prescription, every imaging study and radiology report, and every referral.

Then write down a timeline while it is fresh. Note when symptoms began, when you reported them, what you were told, and when the diagnosis finally came.

That timeline is often the backbone of a malpractice review.

New York also limits how long you have to act. Under CPLR 214-a, a claim for a negligent failure to diagnose cancer generally must be filed within two years and six months of the later of two dates: when you knew or reasonably should have known of the mistake and the harm it caused, or your last continuous treatment.

There is an outer limit of seven years. Claims involving public hospitals have a much shorter notice deadline, so it is worth having your situation reviewed early.

Talk With a New York Cancer Lawyer

Porter Law Group represents patients and families across New York, with offices in Albany, Buffalo, New York City, Rochester, and Syracuse.

If you believe your symptoms were dismissed because you didn’t fit the profile of a “typical” lung cancer patient, our New York cancer lawyers work with board-certified medical experts to review what happened and whether your care met the standard it should have.

Call 833-888-LATE, email info@porterlawteam.com, or request a free case evaluation.

Attorney advertising. This article provides general information and is not legal or medical advice. Prior results do not guarantee a similar outcome. Filing deadlines depend on the facts of each case.

Frequently Asked Questions

What percentage of women with lung cancer never smoked?

In a CDC analysis of seven states, about 15.7% of women diagnosed with lung cancer had never smoked, compared with 9.6% of men. Among women ages 20 to 49, the share rose to 27.7%. Never-smokers make up a higher proportion of female lung cancer patients across every age group studied.

Why is lung cancer increasing in younger women?

Researchers have not identified a single cause. Lung cancer incidence in women under 65 surpassed men’s for the first time in 2021, according to the American Cancer Society. Radon, secondhand smoke, workplace exposures, and tumor biology, including mutations such as EGFR that are more common in women, are all being studied.

Can a woman who never smoked get a lung cancer screening CT in New York?

Not under current screening guidelines, which require a 20 pack-year smoking history. But screening applies only to people without symptoms. A woman with a persistent cough, chest pain, or unexplained weight loss should receive diagnostic imaging based on her symptoms, regardless of whether she has ever smoked.

What lung cancer symptoms in women are most often mistaken for something else?

A cough that lingers for weeks is often treated as bronchitis, asthma, or acid reflux. Chest pain may be attributed to anxiety or muscle strain, and fatigue or weight loss to stress or diet. When these symptoms persist despite treatment, lung cancer should be considered and investigated with imaging.

Can I sue if my doctor didn’t test for lung cancer because I never smoked?

You may be able to. Never having smoked does not excuse a doctor from investigating persistent red-flag symptoms. A claim generally requires showing that a reasonably careful physician would have ordered imaging or a referral, and that the delay allowed the cancer to advance. New York requires expert medical review before filing.